• Tidak ada hasil yang ditemukan

Akt-the Mammalian Target of Rapamycin (mTOR) Pathways Inhibition Increases Cervix Cancer Cells Chemosensitivity to Active Form of Irinotecan (SN-38).

N/A
N/A
Info
Unduh - Bebas
Protected

Academic year: 2017

Membagikan "Akt-the Mammalian Target of Rapamycin (mTOR) Pathways Inhibition Increases Cervix Cancer Cells Chemosensitivity to Active Form of Irinotecan (SN-38)."

Copied!
12
0
0

Memuat.... (Lihat teks lengkap sekarang)

Unduh sekarang ( 12 Halaman )

Teks penuh

Loading

Gambar

Fig. 1 M orphologicalSN-38 Treatment
Fig. 2 The Effect of SN-38 on the GrowthMTT Assay. Concentration-andTime-related
Fig. 3 SN-38 Inducedand PARP Expression
Fig. 4S N -3 8E ffe c t o np -A k t,p -m T O Ra n dp -7 0 S 6 K lW e s te rnB lo t A n a ly s is o f A c tiv eF o rmA k t-m T O RP a th w a y sin H e L a a n d C a S k i C e lls H a rv e s te dfo r th e T im e In d ic a te d(A ) a n dD iffe re n tD o s e (
+2

Referensi

Unduh sekarang ( PDF - 12 Halaman - 10.28 MB )

Garis besar

Akt-the Mammalian Target of Rapamycin (mTOR) Pathways Inhibition Increases Cervix Cancer Cells Chemosensitivity to Active Form of Irinotecan (SN-38).

Dokumen terkait